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The Yeast Hex3䡠Slx8 Heterodimer Is a Ubiquitin Ligase
Stimulated by Substrate Sumoylation*□
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Ubiquitin and small ubiquitin-related modifier (SUMO)5 are
highly conserved proteins that can be covalently attached to
target proteins (1–3). Both ubiquitin and SUMO are attached to
substrates by three types of enzymes: E1, E2, and E3. These
enzymes work consecutively to catalyze isopeptide bond formation between the C terminus of ubiquitin or SUMO and a
lysine side chain of the acceptor protein. In the case of ubiquiti-
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nation, ubiquitin is first activated by the E1 activating enzyme
and is transferred from a thiol group on E1 to a thiol on an E2
conjugating enzyme. The final step of ubiquitin conjugation to
target proteins is facilitated by an E3 ubiquitin ligase, which
binds both E2 and substrate and facilitates ubiquitin transfer to
the substrate. E3s are key mediators of substrate specificity.
Sumoylation happens in an analogous manner to ubiquitin
conjugation, requiring an E1, E2, and usually an E3, of which
only a handful have been identified so far (4, 5). Unlike ubiquitination, which often targets substrates for proteasomal
degradation, SUMO modification is not believed to target
substrates directly to the proteasome. Instead, sumoylation
appears to modulate the functional properties of a protein,
including its localization, activity, and interactions with
other macromolecules.
Similar to ubiquitin regulation, SUMO-protein conjugates
are in a dynamic state, with specialized proteases rapidly
removing the SUMO moieties. In Saccharomyces cerevisiae,
Ulp1 and Ulp2 are the only known SUMO proteases and are
responsible for desumoylating distinct sets of SUMO-modified
proteins (6, 7). Ulp1 is also required for proteolytic maturation
of the SUMO precursor encoded by the SMT3 gene. Like SUMO
itself and the SUMO E1 (the Aos1-Uba2 heterodimer) and E2
(Ubc9), Ulp1 is essential for yeast cell viability. The temperaturesensitive ulp1ts mutant grown at nonpermissive temperature
arrests primarily in the G2/M phase of the cell cycle (7).
To understand the mechanistic basis of ulp1ts lethality and
gain insight into Ulp1 regulation of SUMO dynamics, we
screened a high-copy yeast genomic library for dosage suppressors of ulp1ts. From this screen we isolated the HEX3 gene.
HEX3 (SLX5) was originally identified together with SLX8 as a
gene that becomes essential for viability in the absence of the
Sgs1/Top3 pathway (8). Hex3 and Slx8 form a heterodimer and
localize to the nucleus (9). Deletions of either or both genes
display similar defects in genome stability and are sensitive to
DNA-damaging agents, suggesting that they work interdependently to suppress the accumulation of DNA damage (10). Hex3
and Slx8 each bear a zinc-coordinating RING domain, a motif
characteristic of many ubiquitin and SUMO ligases (E3s). Hex3
also binds SUMO in vivo (11), suggesting that the Hex3䡠Slx8 complex might function by regulating SUMO dynamics. This hypothesis was further supported by the discovery that mutations in
HEX3 and SLX8, like mutations in many known components of
the SUMO pathway, are able to suppress a temperature-sensitive
mutation of the essential Mot1 transcriptional regulator (12).
Here we report that the Hex3䡠Slx8 heterodimer is a ubiquitin ligase. Recombinant Slx8, but not Hex3, exhibits RINGVOLUME 282 • NUMBER 47 • NOVEMBER 23, 2007
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Hex3 and Slx8 are Saccharomyces cerevisiae proteins with
important functions in DNA damage control and maintenance
of genomic stability. Both proteins have RING domains at their
C termini. Such domains are common in ubiquitin and ubiquitin-like protein ligases (E3s), but little was known about the
molecular functions of either protein. In this study we identified
HEX3 as a high-copy suppressor of a temperature-sensitive
small ubiquitin-related modifier (SUMO) protease mutant,
ulp1ts, suggesting that it may affect cellular SUMO dynamics.
Remarkably, even a complete deletion of ULP1 is strongly suppressed. Hex3 forms a heterodimer with Slx8. We found that the
Hex3䡠Slx8 complex has a robust substrate-specific E3 ubiquitin
ligase activity. In this E3 complex, Slx8 appears to bear the core
ligase function, with Hex3 strongly enhancing its activity. Notably, SUMO attachment to a substrate stimulates its Hex3䡠Slx8dependent ubiquitination, primarily through direct noncovalent interactions between SUMO and Hex3. Our data reveal a
novel mechanism of substrate targeting in which sumoylation of
a protein can help trigger its subsequent ubiquitination by
recruiting a SUMO-binding ubiquitin ligase.

The Hex3䡠Slx8 Ubiquitin Ligase

EXPERIMENTAL PROCEDURES
Yeast and Bacterial Methods—Yeast rich (yeast extract/peptone/dextrose) and minimal (SD) media were prepared as
described previously, and standard methods were used for
genetic manipulation of yeast (15). Standard techniques were
used for recombinant DNA work in Escherichia coli.
Yeast Strains—The hex3⌬::kanMX4 and slx8⌬::kanMX4
strains were obtained from Open Biosystems (Huntsville,
AL). They are in the BY4741 strain background. Where indicated, kanMX4 was PCR-amplified with primer pairs corresponding to regions 200 nucleotides upstream and downstream of the HEX3 and SLX8 open reading frame (ORF),
respectively. The deletion cassettes were then transformed
into wild-type (WT) strain MHY501 (16) to generate the
hex3⌬::kanMX4 (MHY3712) and slx8::kanMX4 (MHY3716)
strains. The hex3⌬::kanMX4 slx8⌬::kanMX4 double deletion
strain (MHY3861) was generated from a cross between the
two single mutants.
Plasmids and Mutagenesis—Genomic SLX8, containing the
endogenous promoter and terminator, was PCR-amplified and
cloned into different plasmids. Genomic HEX3 was obtained
from the ulp1ts suppression screen described below, and various fragments were subcloned into the desired plasmids.
YCplac22-ulp1ts-kanMX4 contains the ulp1ts allele present on
a BamHI/PstI fragment. The kanMX4 marker was inserted into
the AflII site (after filling in the overhang with Klenow DNA
polymerase) present 213 base pairs after the stop codon of
ulp1ts. To generate FLAG-tagged Hex3 and T7-tagged Slx8,
FLAG (DYKDDDDKG) and T7 (MASMTGGQQMG) epitope
tags were introduced using PCR-mediated site-directed
mutagenesis. To overexpress and purify Hex3 and Slx8 from
bacteria, both ORFs were PCR-amplified and cloned into
pMALc-HT (a gift from Sean Prigge, JHSOM), thereby adding
an in-frame N-terminal maltose-binding protein (MBP) module followed by a TEV protease cleavage site and a His6 epitope
tag. For the corresponding RING-truncated versions, the PCR
NOVEMBER 23, 2007 • VOLUME 282 • NUMBER 47

reactions were designed to introduce a stop codon at the position of the codon for the last zinc-coordinating Cys residue.
To generate a RING-truncated Hex3 protein for expression
in yeast, a premature stop codon was introduced such that the
last two conserved zinc-coordinating cysteines were deleted.
Specifically, the plasmid pRS425-HEX3 was digested with the
restriction enzyme BspE1, filled in with Klenow polymerase,
and religated to create an allele encoding a truncated Hex3
protein ending at Pro-591 followed by Ala-Gly and a stop
codon. For creating point mutations in the RING domain, Cys561 and Cys-564 of Hex3 and Cys-206 and Cys-209 of Slx8 were
changed to serines by QuikChange mutagenesis (Stratagene).
Rad52 clones for E. coli overexpression were made by inserting
the PCR-amplified RAD52 ORF into pET11d and pET21a (for
T7 epitope tagging; Novagen). A RAD52-SUMO E. coli overexpression clone was generated by inserting the PCR-amplified
SMT3 ORF (lacking the region encoding the C-terminal GlyGly) in-frame with and downstream of RAD52 in pET21a-T7RAD52. In this fusion construct, the major in vitro Rad52
sumoylation site (Lys-220)6 was changed to arginine by QuikChange mutagenesis. For pQE30-TEV-SMT3gg, DNA encoding the mature portion of SUMO (Smt3) was amplified by PCR
and cloned into pQE30 (Qiagen) along with a primer-encoded
N-terminal TEV cleavage site.
Isolation of HEX3 by ulp1ts Suppression—A ulp1ts strain was
generated by replacing the WT ULP1 plasmid in MHY1321,
which lacks the chromosomal copy of ULP1 (17), with
YCplac22-ulp1ts-kanMX4. The strain was co-transformed
with a plasmid expressing mature SUMO (pRS426-GPDFLAG-SMT3gg) (11). The resulting strain was transformed
with a yeast genomic DNA library carried in the 2-LEU2 vector YEp13 (18). Approximately 10,000 Leu⫹ transformants
were isolated at 30 °C and tested for their ability to grow at the
nonpermissive temperature of 37 °C upon replica plating. Of
the 8 clones that supported growth at 37 °C, 6 carried 5⬘ truncated or full-length ULP1 genes. The other two plasmids contained identical DNA inserts from chromosome XVI that
included the HEX3 ORF. A SacI/PacI restriction fragment from
the original isolate containing only the HEX3 ORF was cloned
into the high-copy plasmids pRS425 and pRS423. This fragment was found to be sufficient for full ulp1ts suppression.
Yeast Two-hybrid Assays—Yeast two-hybrid strains containing pOAD- and pOBD2-based plasmids with HEX3 and
SMT3 were a gift from Marissa Vignali (Yeast Resource Center, University of Washington). We initially transformed the
yeast two-hybrid reporter strain PJ69 – 4␣ that contained the
pOBD2-SMT3 bait plasmid with pOAD-HEX3. Subsequently,
pOAD-HEX3 was subject to PCR-mediated site-directed
mutagenesis to generate the series of SIM point mutants (see
“Results”). The resulting pOAD-HEX3-SIM mutants (sim-A,
sim-B, sim-C, sim-D, and sim-A/B) were transformed into the
yeast bait strain, and SUMO (Smt3) interaction was determined
on SD plates lacking adenine. All putative SIM mutations were
confirmed by DNA sequencing.
Recombinant Protein Purification—Hex3, Slx8, and their
derivatives were expressed as MBP fusions in BL21 StarTM
6

L. Krejci and P. Sung, unpublished data.
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dependent auto-ubiquitinating activity. We identified Rad52, a
protein that regulates homologous recombination-dependent
DNA repair, as a model in vitro substrate for Hex3䡠Slx8. Slx8 by
itself has a very weak Rad52-ubiquitin ligation activity that is
strongly stimulated by Hex3. Both the Slx8 and Hex3 RING
domains are required for this activity and for in vivo DNA damage control. Notably, SUMO attachment to Rad52 stimulates
its Hex3䡠Slx8-dependent ubiquitination and enhances binding
between Hex3 and the substrate. Hex3 binds SUMO noncovalently, primarily through two N-terminal SUMO-interacting
motifs (SIMs).
Our data demonstrate that Hex3 and Slx8 work together as a
ubiquitin E3 in which Slx8 appears to provide the core ligase
function and Hex3 enhances Slx8 activity and substrate targeting, in part by binding SUMO in SUMO-protein conjugates.
This novel mechanism of ubiquitin-substrate specificity may
also be relevant to the human BRCA1-BARD1 ubiquitin ligase
implicated in human breast cancer, which also is a heterodimer
of two RING proteins with asymmetric mechanistic contributions from the two RING domains (13, 14).

The Hex3䡠Slx8 Ubiquitin Ligase
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by adding ubiquitinating enzymes and substrate. Reactions
were terminated at the designated times by the addition of 3⫻
SDS gel-loading buffer.
In Vitro Sumoylation Assays—Following Johnson and Gupta
(21), a 50-l reaction for the auto-sumoylation assay contained
the following bacterially expressed recombinant yeast proteins:
2 g of SUMO, 1.1 g of Aos1/Uba2 dimer, and 0.5 g of Ubc9.
Concentrations of recombinant Hex3 and Slx8 were 2.5 and 5
M, respectively. Reactions were performed with 5 mM ATP, 50
mM Tris-HCl, pH 7.0, 100 mM NaCl, 10 mM MgCl2, 1 mM dithiothreitol, and 20 g of bovine serum albumin at 30 °C and were
terminated by boiling in SDS-gel loading buffer. Samples were
resolved by 6 –12% gradient SDS-PAGE and analyzed by antiSUMO immunoblotting (6).

RESULTS
HEX3 Is a High-copy Suppressor of the ulp1ts and ulp1⌬
Mutants—ULP1 encodes an essential yeast desumoylating
enzyme (7). The Ulp1 protease has both an isopeptidase activity, which cleaves SUMO from substrate lysines, and a SUMOprocessing activity that removes the last three amino acids
(ATY) from the SUMO precursor. A free di-glycine sequence at
the mature SUMO C terminus is necessary for its conjugation
to substrates. Deconjugation of SUMO from one or more
unknown proteins by Ulp1 is required for progression through
the G2/M phase of the cell cycle (7).
We reasoned that sumoylation of such a critical substrate(s)
could function to arrest cell cycle progression until certain
other regulatory events had occurred, with subsequent activation or recruitment of Ulp1. Overexpression of the nonsumoylated substrate might, therefore, allow partial bypass of the
ulp1ts block. High levels of other factors regulating G2/M progression or Ulp1 or of another SUMO protease might also suppress the ulp1ts arrest. We, therefore, screened a high-copy
yeast genomic library in ulp1ts cells to identify suppressors of
the conditional growth defect of ulp1ts cells. From ⬃10,000
transformants, 8 clones capable of growth at 37 °C were isolated. Six carried plasmids with ULP1 inserts. The remaining
two suppressing plasmids had identical inserts, and the relevant
gene was determined to be HEX3 (SLX5).
HEX3 encodes a RING-domain protein involved in genome
maintenance (8, 10). Importantly, the ability of HEX3 to suppress the growth defect of ulp1ts at the nonpermissive temperature depended on co-expression of SMT3gg, encoding mature
SUMO. Alone, neither HEX3 nor SMT3gg was able to rescue
the ulp1ts mutant, but the combination of both genes on separate high-copy plasmids supported robust growth of ulp1ts cells
at 37 °C (Fig. 1A, top panel). This implied that high dosage
HEX3 specifically suppressed the SUMO isopeptidase defect of
the ulp1ts mutant but did not restore SUMO-precursor processing. In support of this, provision of an SMT3aty expressing
plasmid encoding the unprocessed SUMO precursor did not
support growth of ulp1ts cells carrying high-copy HEX3 (Fig.
1B). Remarkably, high-copy of HEX3 was also capable of suppressing a complete deletion of ULP1 both at 30 °C (Fig. 1A,
bottom panel) and 37 °C (supplemental Fig. S1A). In contrast,
increased Hex3 expression did not suppress the temperatureVOLUME 282 • NUMBER 47 • NOVEMBER 23, 2007
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(DE3) cells containing plasmid pRIL, which expresses several
rare-codon tRNAs (a gift from Sean Prigge, JHSOM, MD). Proteins were affinity purified on an amylose resin (New England
Biolabs). Rad52 was expressed and purified according to Song
and Sung (19). T7-tagged Rad52 and the T7-Rad52-SUMO
fusion were expressed as above and purified on a Talon Superflow column (BD Biosciences). Bacterially expressed His6-Ubc4
was purified as in Bays et al. (20), and yeast SUMO was purified
from bacteria carrying pQE30-TEV-SMT3gg according to
Johnson and Gupta (21).
Immunoprecipitation and Pulldown Assays—For SUMO
pulldown experiments, 20 nM recombinant Hex3, Slx8, or MBP
was incubated with SUMO-1-agarose (BostonBiochem) or, as a
control, protein A-agarose (Repligen) in 0.5 ml of buffer containing 0.5% Triton X-100, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1⫻ protease inhibitor mixture (Roche
Applied Science) and 50 mM HEPES, pH 7.5. Proteins pulled
down with beads were washed in the same buffer except with
1% Triton X-100 and 200 mM NaCl. For Rad52/Rad52-SUMO
co-immunoprecipitation with Hex3, 10 nM recombinant Hex3,
Slx8, or MBP were incubated with 10 nM T7-tagged Rad52 or
Rad52-SUMO in 1 ml of buffer containing 1% Triton X-100,
150 mM NaCl, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1⫻ protease inhibitor mixture, 0.1 M bovine serum albumin, and 50 mM HEPES, pH 7.5. After incubation with anti-T7
monoclonal antibody (Novagen), samples were precipitated by
protein A-agarose. Precipitates were washed in the same buffer
but containing 1 M NaCl.
In Vitro Auto-ubiquitination Assay—Based on the procedures used in Swanson et al. (22), a typical 20-l reaction for
Slx8 and Hex3 auto-ubiquitination contained 0.4 g of yeast
Uba1 (BostonBiochem), 0.2 g of human His6-Ubc4 (20), 2.5
g of human recombinant ubiquitin (Boston Biochem), 10 mM
ATP, and 2 M recombinant wild-type Hex3, Slx8, or their
respective RING mutants in reaction buffer (2.5 mM MgCl2, 0.5
mM dithiothreitol, and 50 mM Tris䡠HCl, pH 7.5). Reactions were
allowed to proceed at 30 °C for 2 h and were terminated by
adding 3⫻ SDS gel-loading buffer. The resulting ubiquitin conjugates were analyzed by immunoblotting with an anti-ubiquitin monoclonal antibody (Covance). To detect the ubiquitinated His6-tagged proteins from the auto-ubiquitination assay,
samples from the reaction were resolved on 8% SDS-PAGE gels
and probed with an anti-His4 antibody (Qiagen).
In Vitro Rad52 Ubiquitination Assay—Unless otherwise
noted, Rad52 and Rad52-SUMO ubiquitination assays contained 0.3 g of yeast Uba1, 0.2 g of human His6-Ubc4, 1.2 g
of human recombinant ubiquitin, and 10 mM ATP in a 20-l
reaction as above. Different concentrations of recombinant
Hex3, Slx8, and the respective RING mutants and of recombinant Rad52 or Rad52-SUMO were used between reactions and
are reported in the figure legends. Ubiquitinated Rad52 and
Rad52-SUMO were resolved on 8% SDS-PAGE gels and analyzed by immunoblotting with anti-Rad52 (23) or anti-T7
(Novagen) antibodies. For SUMO competition assays, recombinant Hex3 and Slx8 were preincubated with 10 g of recombinant
yeast SUMO in reaction buffer (100 mM NaCl, 0.1 mM MgCl2, 0.1
mM dithiothreitol, 10% glycerol, and 50 mM Tris䡠HCl, pH 7.5) for
30 min at 4 °C. Reactions were transferred to 30 °C and initiated
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FIGURE 1. HEX3 is a high-copy suppressor of ulp1 mutants and requires
mature SUMO (Smt3gg) and SLX8 for suppression. A, upper panels, the
ulp1ts strain was transformed with plasmids containing either SMT3gg, HEX3,
or both, as indicated. After spotting cells in 10-fold serial dilutions, plates were
incubated at 30 and 37 °C for 3 days. Lower panels, A ulp1⌬ strain (MHY1321)
expressing WT ULP1 from a URA3 plasmid was transformed with high-copy
plasmids bearing the indicated genes. Transformants were spotted on minimal plates or plates containing 5-fluoro-orotic acid (5-FOA) and incubated at
30 °C for 3 days. 5-FOA selected against the ULP1-URA3 plasmid. B, plasmids containing either no insert, SMT3gg, or SMT3aty (expressing the
unprocessed precursor of SUMO) were transformed into ulp1ts cells carrying a high-copy HEX3 plasmid. Transformants were streaked on plates
and incubated at either 30 or 37 °C. C, SLX8 was deleted from a yeast strain
with a chromosomal deletion of ULP1 but with a ULP1-URA3 plasmid. Additional plasmids expressed mature SUMO and high levels of Hex3. SLX8 and
slx8⌬ strains were streaked on minimal (SD) or 5-FOA plates and incubated
at 30 °C for 3 days. D, SUMO conjugate levels in WT and mutant cells.
Whole cell extracts from the indicated strains (⌬⌬, hex3⌬ slx8⌬) were
resolved by 5–12% gradient SDS-PAGE and analyzed by anti-SUMO immunoblotting. GelCode Blue staining of the SDS-PAGE gel showed comparable loading of proteins. Positions of free SUMO, high molecular weight
(HMW) SUMO conjugates (right bracket), the stacking gel (left bracket), and
molecular weight markers are indicated.

sensitive growth defect of ulp2⌬ cells. ULP2 encodes a second
SUMO protease with distinct specificity and function (6).
SLX8 encodes another RING-containing protein that forms a
heterodimer with Hex3 (8, 9). Both polypeptides are required
for DNA damage resistance and maintenance of genome stability (8, 10). Although high-copy SLX8 was unable to suppress the
ulp1ts growth defect at 37 °C (data not shown), deletion of SLX8
in a strain lacking ULP1 prevented high-copy HEX3 and
SMT3gg from rescuing growth (Fig. 1C). These data are consistent with a role for both Hex3 and Slx8 in regulating SUMONOVEMBER 23, 2007 • VOLUME 282 • NUMBER 47

conjugate dynamics and suggest that Hex3, but not Slx8, is normally expressed at limiting levels.
Comparison of SUMO conjugates in WT, hex3⌬, slx8⌬, and
hex3⌬ slx8⌬ double mutant (⌬⌬) cells by anti-SUMO immunoblotting revealed significantly greater levels of high molecular
mass sumoylated species (greater than ⬃150 kDa, including
material in the stacking gel) in the mutants relative to WT cells
(Fig. 1D). Therefore, both Hex3 and Slx8 have a major role in
limiting cellular SUMO-protein levels, consistent with previous
observations (12). Because loss of these RING proteins causes
an increase in SUMO conjugates, it is unlikely that they are
SUMO ligases. They could function as components or activators of a SUMO protease or could reduce sumoylated protein
levels by some other mechanism. We explore these possibilities
below.
Recombinant Hex3 Binds to SUMO—Hex3 was previously
reported to bind SUMO in yeast, and the interaction was insensitive to overexpressed Ulp1 protease (11), suggesting that
Hex3 might associate with SUMO in a noncovalent manner. To
test this, purified recombinant Hex3 fused with MBP (Fig. 2B,
left panel) was incubated with human SUMO-1 coupled to agarose beads or, as a control, protein A-agarose. Proteins pulled
down with the different resins were eluted and analyzed by
anti-MBP immunoblotting (Fig. 2C). This assay revealed that
MBP-Hex3, but not MBP alone, was able to bind specifically to
SUMO. These data suggest that the effect of Hex3 on cellular
SUMO dynamics may be based on a direct interaction between
Hex3 and the SUMO polypeptide.
Interaction between Hex3 and SUMO Depends on SUMOinteracting Motifs in Hex3—From the Hex3 protein sequence,
we identified a series of potential SIMs based on previously
proposed SIM consensus sequences (11, 24, 25). A typical SIM
features a patch of aliphatic residues often neighboring a cluster
of acidic amino acids (26). Based on these criteria, we identified
SIM-A and SIM-B in Hex3 together with two additional weak
JOURNAL OF BIOLOGICAL CHEMISTRY

34179

Downloaded from http://www.jbc.org/ at VIVA, College of William & Mary on February 17, 2017

FIGURE 2. Recombinant Hex3 interacts with SUMO in vitro. A, schematic of
Hex3 and Slx8 proteins with Hex3 SIMs and RING domains highlighted.
B, purification of MBP fusions of Hex3 and Slx8 from E. coli cell extracts. Proteins were harvested from multiple elutions with maltose-containing buffer.
Elutions 1 and 2 (E1, E2) were resolved by 8% SDS-PAGE. Size standards are
indicated on the left. C, direct interaction between Hex3 and SUMO was determined by an in vitro pulldown assay. Recombinant MBP (New England Biolabs) and MBP-Hex3 were incubated with either SUMO-1-agarose or protein
A-agarose. Precipitated proteins were run on 8% SDS-PAGE gels and detected
by anti-MBP (Santa Cruz) immunoblotting (WB, lanes 3– 6). Lanes 1–2, input
(3.33%) MBP and MBP-Hex3.
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FIGURE 3. The interaction of Hex3 with SUMO involves two SIMs. A, potential Hex3 SIMs and their mutated sequences tested by yeast two-hybrid
assays. Numbers denote positions in the Hex3 sequence. B, top, sectors of
plate indicate the different prey constructs (WT, sim-A, sim-B, sim-C, sim-D,
sim-A/B, and empty vector) tested for interactions with the Smt3/SUMO bait.
The presence of both SMT3 (pOBD2/TRP1) and HEX3 (pOAD/LEU2) constructs
was confirmed by growth on medium lacking tryptophan and leucine (top
plate). Interaction between Hex3 and SUMO results in growth of cell patches
(in triplicate) on medium lacking adenine (bottom plate). C, SUMO conjugates
in hex3⌬ cells transformed with a low-copy plasmid carrying WT HEX3, the
sim-A/B HEX3, or no insert. Immunoblot analysis was done with anti-SUMO
antisera; blots were re-probed with anti-Pgk1 to verify equal protein loading.
HMW, high molecular weight.

matches (SIM-C and SIM-D) (Fig. 3A, WT column). To test the
role of these putative SIMs in Hex3-SUMO interaction, we
mutated each of them by substituting multiple hydrophobic
residues with alanines (Fig. 3A, mutant column). Interactions
between Hex3 mutants and SUMO were then tested by the
yeast two-hybrid assay. Disruption of SIM-B, -C, or -D individually did not affect SUMO binding, but the SIM-A mutation
partially impaired Hex3-SUMO interaction as measured by cell
growth on SD⫺adenine plates. Simultaneous mutation of
SIM-A and SIM-B greatly reduced Hex3-SUMO association by
this assay (Fig. 3B). The simA/B in Hex3 did not cause reduced
expression of the protein relative to WT Hex3 (supplemental
Fig. S2A). We note that purified recombinant Hex3-simA/B
could still bind SUMO in vitro (not shown), so additional
SUMO binding sites must exist in the protein. These data indicate that Hex3 uses partially redundant SIMs, SIM-A and
SIM-B, as well as additional elements to interact with SUMO
and/or sumoylated proteins.
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To test if the hex3-sim-A/B double mutant exhibited any
functional defects in vivo, plasmids expressing WT or sim-A/B
mutant Hex3 were transformed into hex3⌬ cells. The hex3-simA/B mutant complemented hex3⌬ for hydroxyurea and UV
resistance (data not shown). However, compared with wildtype cells, hex3-sim-A/B cells displayed increased levels of high
molecular weight SUMO conjugates (Fig. 3C). The modest
inhibition of Hex3 function by the sim-A/B mutations is consistent with the failure of these mutations to fully block SUMO
binding.
The RING Domains of Hex3 and Slx8 Are Required for UV
and Hydroxyurea Resistance—As previously noted, both Hex3
and Slx8 contain potential zinc-coordinating RING domains,
which are often associated with ubiquitin and SUMO ligases (2,
8, 12, 27). It has been reported that the RING of Slx8 is essential
in sgs1⌬ cells, suggesting that this RING contributes to Slx8
function in this context (9). We tested the requirement for the
RING domains of both Slx8 and Hex3 when cells were subjected to DNA damage stress. Two predicted zinc-coordinating
cysteines were changed to serines in each protein RING domain
(Fig. 4A). Plasmid-borne alleles encoding the RING mutants or
wild-type proteins were introduced into hex3⌬ or slx8⌬ cells. The
transformants were then tested for growth after UV irradiation or
on hydroxyurea (HU)-containing medium (Fig. 4, B and C).
As expected, WT Hex3 and Slx8 expressed from either low
(CEN) or high-copy (2) plasmids fully complemented the
growth defects of the respective deletion strains. In contrast,
the RING-mutated alleles failed to rescue the hex3 or slx8 null
mutants (Fig. 4, B and C). The hex3-SS and slx8-SS alleles were
tested on high copy (2) plasmids to allow their detection as
epitope-tagged proteins (supplemental Fig. S2), but even when
expressed at higher levels than the tagged WT proteins they
failed to complement the corresponding hex3⌬ and slx8⌬
mutations (as was true for the CEN plasmid-borne mutant alleles; data not shown). Because we had identified HEX3 as a suppressor of ulp1 mutants, we also tested whether overexpression
of a HEX3 RING domain truncation in combination with
SMT3gg rescued growth of the ulp1⌬ strain. As shown in Fig.
4D, it did not. These data raise the possibility that high-copy
HEX3 suppression of both DNA damage sensitivity and the
ulp1 cell division defect may occur by related mechanisms.
Slx8 Exhibits RING-dependent Auto-ubiquitination Activity—
Given the presence of RING domains in both Hex3 and Slx8, we
determined whether they might have SUMO-ligase or ubiquitin-ligase activity. Because of their genetic links to the SUMO
pathway, we first examined potential SUMO ligase function.
Both purified recombinant proteins enhanced polySUMO
chain formation by low concentrations of SUMO E1 (Aos1/
Uba2) and E2 (Ubc9) (supplemental Fig. S3A). Although these
data suggested that Hex3 and/or Slx8 might have significant
polySUMO chain-stimulating activity, in neither case did this
activity require an intact RING domain (supplemental Fig.
S3A), so its physiological relevance remains unclear. We also
tested in vitro sumoylation of the DNA repair protein Rad52,
which is sumoylated in vivo (see below). Even at very high
E3:substrate ratios (⬃10:1), only minimal modification was
seen, and a control that mixed a known SUMO E3, Siz1, with
Slx8 showed more activity than did Hex3-Slx8 (supplemental
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A.
5-FOA -LEU

B.

P

x8

x3
He

Sl

ø

MB

SMT3gg

4)
EB
(T 3
NG ex
RI + H
x8 ex3
Sl
H

-LEU

5

Sl
x3
He
P
MB

40

80

Rad52-Ubn

+

Hex3

ø

60

Rad52

120
100

T7-Rad52-Ubn

x8

Hex3RING

150
100
75

30
GST

T7-Rad52
50

FIGURE 4. The RING domains of Hex3 and Slx8 are required for cellular
DNA damage resistance. A, schematic of WT and mutant RING domains of
Hex3 and Slx8 tested in this study. Conserved cysteine (C) and histidine (H)
residues are shown in light face; serine (S) mutations are shown in bold.
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FIGURE 6. Yeast Rad52 protein is a substrate for Hex3䡠Slx8-mediated
ubiquitination. A, recombinant yeast Rad52 (0.2 M) was incubated at 30 °C
for 2 h with E1 (Uba1), E2 (Ubc4), and 0.4 M of the indicated recombinant
proteins (lane 5–10). Control reactions lacking E3 or with MBP (lanes 4 –5) or
containing purified GST in place of Rad52 (lane 1–3) are also shown. B, equal
amounts (0.4 M) of recombinant Hex3 or Hex3-RING⌬ were supplied to separate ubiquitination reactions containing Uba1, Ubc4, Slx8, and 0.2 M
T7-tagged recombinant Rad52. Reaction products were examined by anti-T7
immunoblotting. GST, glutathione S-transferase.

Fig. S3B). The increase in levels of high molecular weight
SUMO conjugates in hex3⌬ and slx8⌬ yeast (Fig. 1D), instead of
a decrease, also appears inconsistent with a general role for the
two proteins as canonical SUMO ligases.
We, therefore, assayed Hex3 and Slx8 for potential ubiquitin
ligase activity. Both proteins were analyzed by an in vitro autoubiquitination assay with E1 (Uba1) and E2 (Ubc4). The reaction products were analyzed by anti-ubiquitin immunoblotting
(Fig. 5A). Notably, Slx8 catalyzed formation of large ubiquitinated species (Fig. 5A, lane 7), but Hex3 did not (lane 6). The
Slx8-RING⌬ mutant also failed to stimulate ubiquitin conjugate formation (lane 8). At least a fraction of the ubiquitinated
species represented Slx8-ubiquitin conjugates (Fig. 5B, lane 3).
These data were similar to the positive control, the RING of a
known ubiquitin E3, TEB4 (28). Neither Hex3 nor the Slx8RING⌬ proteins became ubiquitin-modified. Together, these
data indicate that Slx8 has a RING-dependent self-ubiquitinating activity similar to that of other RING E3 ubiquitin ligases.

Hex3 Facilitates Slx8-directed Ubiquitination of Yeast Rad52
Protein—A growing body of genetic data has implicated Hex3
and Slx8 in the control of DNA damage (8, 10, 29). The results
presented above suggest that Slx8, potentially with Hex3, may
help control DNA damage through a ubiquitin ligase activity.
Conceivably, substrates of Slx8 could be regulators or effectors
of the DNA-damage response. Therefore, we tested several
candidate substrates of Hex3䡠Slx8 for in vitro ubiquitination. Of
several purified proteins tested, the Rad52 protein, which functions in DNA repair and homologous recombination, was
found to be weakly ubiquitinated by Slx8 (Fig. 6, lane 6) but not
by Hex3 alone (lane 8) or by the truncated Slx8-RING⌬ protein
(lane 7). Activity was greatly stimulated by the addition of Hex3
(lane 9). The identity of the slower migrating Rad52-reactive
bands in Fig. 6A as multiubiquitinated species was confirmed
by their reduced mobility when hemagglutinin-tagged ubiquitin replaced ubiquitin in the reaction (data not shown). The
RING domain of TEB4 did not ubiquitinate Rad52 (Fig. 6A, lane
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10) nor was purified Rad51, another homologous recombination protein, modified by Hex3䡠Slx8.7
Given that the RING of Hex3 is required for its in vivo function (Fig. 4, B and D), we also tested its importance in Rad52
ubiquitination in vitro. Whereas wild-type Hex3 strongly activated Slx8-dependent Rad52 ubiquitination, the Hex3-RING⌬
truncation failed to enhance the reaction (Fig. 6B). These data
are consistent with a model in which the RING domains of both
Slx8 and Hex3 contribute to the ubiquitin ligase activity, with
Slx8 likely functioning as the core ligase that is activated by
Hex3. This arrangement is reminiscent of the human BRCA1BARD1 RING heterodimer, in which the BRCA1 RING is the
crucial E3 effector, but both polypeptides are needed for maximal activity (30, 31).
Role of SUMO in Hex3䡠Slx8-mediated Rad52 Ubiquitination—Hex3 both associates with SUMO (Fig. 2C) and enhances
the Rad52-specific ubiquitin ligase activity of Slx8 (Fig. 6A).
Notably, Rad52 becomes sumoylated after DNA damage (32,
33). We, therefore, hypothesized that Hex3䡠Slx8-mediated
ubiquitination of Rad52 might be stimulated by Rad52-SUMO
ligation. Direct translational fusion of SUMO to substrates
often mimics the effects of post-translational SUMO addition
to the same proteins in vitro and in vivo (34 –36). We adopted
this strategy and generated a Rad52-SUMO fusion that could be
purified from E. coli and used in our in vitro ubiquitination
system (Fig. 7A). When equimolar amounts of recombinant
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FIGURE 7. Hex3䡠Slx8 is a SUMO-directed ubiquitin ligase for Rad52.
A, schematic of T7-tagged Rad52 and Rad52-SUMO fusion proteins. B, Rad52SUMO fusion is a better substrate than Rad52 for in vitro Hex3䡠Slx8-mediated
ubiquitination. Equal amounts of recombinant Rad52 and Rad52-SUMO (0.4
M) were used in the ubiquitination (Ubn) reactions together with Uba1,
Ubc4, and 0.2 M each of Hex3 and Slx8. Reactions were conducted at 30 °C
for the indicated times, and reaction products were examined by anti-T7
immunoblotting. C, co-precipitation of Hex3 with Rad52-SUMO. Rad52SUMO was incubated with Hex3, Slx8, and MBP before immunoprecipitation
with anti-T7 antibodies. Precipitated proteins were resolved by 8% SDS-PAGE
followed by anti-MBP immunoblotting. Lanes 1–3 denote 3.33% input of
Hex3, Slx8, and MBP. D, co-immunoprecipitation (IP) of Hex3 and Slx8 with
Rad52. The experiment is identical to that in panel C except that Rad52 was
used instead of Rad52-SUMO.

P. Chi and P. Sung, unpublished data.
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FIGURE 8. Ubiquitination of Rad52-SUMO is specifically inhibited by
excess free SUMO. A, 0.2 M each of Hex3 and Slx8 were incubated with
purified SUMO present in 100-fold molar excess relative to substrate or with
buffer alone for 30 min before being introduced into the Rad52-SUMO (0.4
M) ubiquitination (Ubn) assay. Immunoblotting was done as in Fig. 7B.
B, similar free SUMO inhibition assay as in A except that Rad52 (0.4 M) was
used as a substrate. C, ubiquitination of Rad52 was carried out as B but
with elevated amounts of Hex3 and Slx8 (Hex3䡠Slx8/substrate ⫽ 0.4
M/0.2 M). Rx, reaction.

Rad52 and Rad52-SUMO were tested as Hex3䡠Slx8 ubiquitination substrates under suboptimal conditions, Rad52-SUMO
was efficiently ubiquitinated, whereas Rad52 alone was only
modified to a limited degree (Fig. 7B).
Rad52-SUMO might be a better ubiquitination substrate
because Hex3䡠Slx8 can bind the SUMO moiety and enhance
E3-substrate interaction. We tested this idea by comparing the
ability of anti-T7 antibodies to co-precipitate T7-tagged Rad52
or Rad52-SUMO and either Hex3 or Slx8. With T7-Rad52SUMO, only MBP-Hex3 was detectably co-precipitated,
whereas MBP-Slx8 and MBP were not (Fig. 7C). When
T7-Rad52 was precipitated, neither MBP-Hex3 nor MBP-Slx8
was detected above background (Fig. 7D). These data suggest
that Rad52-SUMO preferentially binds to Hex3 (in Hex3䡠Slx8),
which in turn may account for the enhanced Slx8-mediated
ubiquitination of this protein.
If enhanced ubiquitination of Rad52-SUMO compared with
Rad52 was due to direct E3-SUMO binding, then excess free
SUMO should selectively inhibit Rad52-SUMO ubiquitin ligation. Using a 100-fold excess of free SUMO relative to substrate,
ubiquitination of Rad52-SUMO was indeed impaired (Fig. 8A).
In contrast, the same free SUMO/substrate ratio had little, if
any, effect on the ubiquitination of Rad52 lacking the SUMO
moiety (Fig. 8B). Although increasing the concentration of
Hex3䡠Slx8 enhanced Rad52 ubiquitination, this modification
was still largely unaffected by the presence of free SUMO (Fig.
8C). We note that the Hex3-simA/B mutant, which can still
bind SUMO in vitro, also still could stimulate Rad52-SUMO
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ubiquitination (data not shown). In summary, our findings suggest that the Hex3䡠Slx8 complex is a substrate-specific ubiquitin ligase that is stimulated by prior attachment of SUMO to
the substrate.
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FIGURE 9. Proposed model for Hex3䡠Slx8 function. For details, see
“Discussion.”

bled” colony morphology, elevated frequencies of recombination, and sensitivity to certain DNA damaging agents (8, 29, 44,
45). The model in Fig. 9 predicts that Ulp1 and Hex3䡠Slx8 have
overlapping functions in the cell cycle and in controlling the
accumulation of DNA damage. This view is consistent with
the strong synthetic defects observed in the ulp1ts hex3⌬ double mutant (supplemental Fig. S1B).
Our results support the idea that SUMO attachment to protein substrates provides the nexus where regulation by Ulp1
and Hex3-Slx8 directly intersect. This is self-evident for desumoylation by Ulp1, but the recruitment of a ubiquitin ligase to
a substrate by prior substrate sumoylation has not been
reported previously. The in vitro data suggest that direct Hex3SUMO binding is responsible for facilitating association of the
Hex3䡠Slx8 ligase with the sumoylated target protein. Two partially redundant SIMs in Hex3, SIM-A and SIM-B, contribute to
SUMO binding. Despite the importance of SIM-A and SIM-B
for SUMO association by the two-hybrid assay, the only phenotypic defect we detected with the hex3-sim-A/B mutant was
an enhanced accumulation of high molecular mass SUMO conjugates. Residual SUMO or polySUMO binding presumably
still occurs with the mutant Hex3 protein in vivo as it does in
vitro. It is also clear that Hex3䡠Slx8 is active in vitro toward
nonsumoylated substrates, at least at high concentrations (Fig.
6), so it is possible that low SUMO-independent activity is sufficient under many circumstances in vivo.
We identified Rad52 as an in vitro substrate of the Hex3䡠Slx8
ubiquitin ligase. Interestingly, a recent study reported genetic
interactions between mutations in HEX3/SLX8 and RAD52
that are consistent with the Hex3䡠Slx8 complex negatively regulating Rad52-dependent recombination when such activity
would induce DNA damage (29). Our model (Fig. 9) would
predict enhanced Hex3䡠Slx8-mediated ubiquitination of
sumoylated Rad52. Rad52 is strongly sumoylated in vivo after
certain types of DNA damage and can be degraded by the ubiquitin-proteasome pathway (32).8 However, neither Rad52 nor a
Rad52-SUMO fusion was degraded more slowly in hex3⌬ or
slx8⌬ cells than in WT cells (data not shown). It remains possible that Hex3䡠Slx8-mediated Rad52 ubiquitination does not
8

Y. Xie, O. Kerscher, and M. Hochstrasser, unpublished results.
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DISCUSSION
In this study, we have demonstrated that the Hex3䡠Slx8 complex functions as a ubiquitin-protein ligase (E3). Full activity
requires the RING domains of both Hex3 and Slx8, but it
appears that Slx8 possesses the core ligase activity. Hex3
enhances E3 activity toward its substrates. Surprisingly, one
way by which Hex3 appears to stimulate substrate ubiquitination is by binding conjugated SUMO in a target protein. This is
the first example of such a mechanism of substrate-specific
cross-talk between the SUMO and ubiquitin systems but is
likely to be utilized more broadly. Related findings on the Hex3Slx8 ubiquitin ligase are published in the accompanying article
by Uzunova et al. (50).
There are two examples in higher organisms of heterodimeric RING proteins catalyzing substrate ubiquitination,
BRCA1-BARD1 and RING1a/b-BMI1 (30, 31, 37, 38). Like
Hex3-Slx8, the BRCA1-BARD1 complex also functions in the
control of DNA damage (39, 40). Mutation of the RING domain
in either Hex3 or Slx8 results in a null phenotype in every assay
done to date (Ref. 9; this study). Because Slx8 by itself has a
robust auto-ubiquitinating activity as well as a weak activity in
the trans-ubiquitination of Rad52, Slx8 presumably interacts
directly with the E2 enzyme Ubc4 to promote ubiquitination, as
in a canonical ubiquitin RING E3 (2, 41). The exact function of
the Hex3 RING is less clear. These findings are also reminiscent
of the BRCA1-BARD1 RING heterodimer, where the BRCA1
RING but not BARD1 binds UBCH5c, which is in the same E2
subfamily as yeast Ubc4 (14). Similar findings have been
reported for the RING1a/b-BMI1 RING protein heterodimer,
where the BMI1 protein has no detectable intrinsic E3 activity,
although its RING is essential for activity of the complex (42,
43). For Hex3 as well as BARD1 and BMI1, the RING might
stabilize an active conformation of the partner RING.
One of the more remarkable observations of the current
study is that modest overproduction of the Hex3 protein allows
for a complete bypass of the normally essential role played by
the Ulp1 SUMO isopeptidase in cell cycle progression (Fig. 1A
and supplemental Fig. S1A). Because there is no detectable
alteration to bulk SUMO-conjugate patterns under these conditions (data not shown), it is unlikely that Hex3 or a Hex3regulated factor functions as a SUMO protease that can substitute for Ulp1. In Fig. 9, we present a general model for the
function of Hex3-Slx8 and the suppression of ulp1⌬ by
increased levels of the Hex3-Slx8 heterodimer. Specifically,
we suggest that a protein(s) (X) is sumoylated and that in this
modified form it more strongly inhibits progression through
the G2/M phase of the cell cycle. Ulp1 can counteract this
inhibitory mechanism by desumoylating the X protein(s).
Alternatively, upon increasing levels of Hex3, which we assume
is present in limiting amounts relative to Slx8, enhanced ubiquitination of the inhibitory sumoylated factor leads to its inactivation, presumably by proteasomal degradation. Mutant hex3
and ulp1 strains share several characteristics, including a “nib-

Inhibit cell cycle
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lead to its degradation or that such modification only affects a
specific fraction of Rad52, which we failed to observe. By
genetic criteria, Hex3 and Slx8 appear to have only a partial
functional overlap with the Rad52-dependent repair pathway
(29, 46, 47). We suspect that the Hex3䡠Slx8 E3 can ubiquitinate
other substrates that participate in DNA damage control and
predict that they are also conditionally sumoylated.
Apparent homologs of Hex3 and Slx8 are found in Schizosaccharomyces pombe and higher organisms, including humans
(8, 48). The human RNF4 protein has ubiquitin ligase activity
and can also bind SUMO noncovalently (49). Whether such
binding stimulates its ubiquitin ligase activity toward specific
sumoylated substrates is not yet known. However, it seems
likely that our proposed model for yeast Hex3䡠Slx8 regulation
and activity will be more broadly applicable. The BARD1 protein also has several good matches to the SIM consensus
sequence; the possibility that the BARD1-BRCA1 ubiquitin
ligase is also regulated by substrate sumoylation is intriguing
given the other similarities with yeast Hex3-Slx8 noted above. A
thorough understanding of the mechanistic and physiological
functions of Hex3䡠Slx8 and its homologs will require further
biochemical and biophysical analysis of their SUMO-dependent and -independent ubiquitin ligase activities as well as identification and characterization of their natural in vivo
substrates.

Supplemental Figure S1. A. Mutant ulp1∆ and ulp2∆ cells with URA3 plasmids bearing ULP1 and
ULP2, respectively, were transformed with both HEX3 and SMT3gg 2µ plasmids. Transformants were
grown for 3 days on minimal medium (SD) at 30°C and on 5-FOA plate at 37°C to evict the URA3
plasmids. B. Growth phenotypes of WT, ulp1ts, hex3∆ and ulp1ts hex3∆ cells were compared at various
temperatures as well as under various DNA-damaging treatments at 30˚C, as indicated.
Supplemental Figure S2. A. Extracts from the yest two-hybrid tester strain expressing Gal4 activation
domain (AD) fusions to WT Hex3 or Hex3-simA/B or an empty vector control were subjected to
immunoblot analysis with an anti-AD monoclonal antibody (Clonetech). B. Whole cell extracts from
hex3∆ transformants with the indicated plasmids encoding FLAG-tagged Hex3 proteins were resolved by
8% SDS-PAGE and examined by anti-FLAG immunoblotting. Nonspecific bands above and below Hex3
are marked by *. Another nonspecific band labeled by ** served as a loading control. C. Extracts from
slx8∆ cells transformed with the indicated T7-tagged SLX8 constructs. Anti-T7 antibodies were utilized to
detect Slx8. A weak nonspecific band (**) was used as a loading control.
Supplemental Figure S3. A. In vitro auto-sumoylation assay. SUMO, E1, E2, and ATP were mixed with
the indicated proteins; after 90 min at 30˚C, samples were resolved by SDS-PAGE and analyzed by antiSUMO immunoblotting. *, a nonspecific band in the Hex3- and Slx8-containing reactions. **, Hex3,
which weakly cross-reacts with the anti-rabbit secondary antibody (GE Healthcare). B. In vitro
sumoylation of Rad52. Reaction conditions were similar to those in panel A except 0.1 µM Rad52 was
added. Immunoblotting was done with an anti-Rad52 antibody.
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